Live Chat

$9 Billion dollar Verdict against Takeda and Eli Lilly in Actos Trial

Takeda Pharmaceuticals and Eli Lilly hit with a $9,000,000,000.00 billion dollar verdict arising from the sale and distribution of their defective drug, Actos.  Our Actos Lawyers are pleased with the outcome of this case tried by Mark Lanier and we congratulate him and his firm.  Pharmaceutical manufacturers need to be aware of the dangers posed by drugs distributed to consumers–and most importantly, patients need to be warned about these dangers.  

Legal Commentary 

The verdict is staggering and exemplifies what can happen to Corporations that place Profit over the safety of Patients.  The case was presented in part on a Failure to Warn theory, as the warning did not adequately inform users of the risk of developing Bladder Cancer arising from Actos use.  As an Actos lawyer, I believe Takeda should have warned about the danger of Actos induced bladder cancer as soon as they had a suspicion that it may harm consumers–this simply did not happen–and it should have.  As a result of this omission, Takeda and Eli Lilly, companies that manufactured, produced and distributed Actos were taken to task by this Jury and will pay for their wrongdoing by having to deal with a $9,000,000,000 verdict.  The consolidated Actos cases in Louisiana are In Re Actos (Pioglitazone) Products Liability Litigation, 11-md-02299. Allen’s case is Allen v. Takeda Pharmaceuticals North America Inc., 12-cv-00064, both in U.S. District Court, Western District of Louisiana (Lafayette).

About the Author

Majed Nachawati is a preeminent Actos Pharmaceutical Products Liability Lawyer with a focus on representing Actos victims and families harmed by dangerous implantations on a nationwide basis—especially the Actos device. Mr. Nachawati has resolved numerous cases through trials and settlements that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas, and is in most federal courts in the nation and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati has also been voted as one of only 500 lawyers as one of the Best Mass Tort Lawyers in Dallas by D Magazine. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at or by calling 1.866.705.7584.


Drug Litigation

Takeda hit with $9 Billion Dollar Verdict over Actos drug and Bladder Cancer